• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    France Poultry Vaccines Market

    ID: MRFR/Pharma/48779-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    France Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    France Poultry Vaccines Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    France Poultry Vaccines Market Summary

    The France Poultry Vaccines market is projected to grow significantly from 135 million USD in 2024 to 260 million USD by 2035.

    Key Market Trends & Highlights

    France Poultry Vaccines Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 6.14 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 260 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 135 million USD, reflecting a solid foundation for future expansion.
    • Growing adoption of advanced vaccination technologies due to increasing poultry health awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 135 (USD Million)
    2035 Market Size 260 (USD Million)
    CAGR (2025-2035) 6.14%

    Major Players

    Synergen, Cegelec, Lohmann Animal Health, Biovac, MSD Animal Health, Zoetis, Vetoquinol, Elanco, IDT Biologika, Merck Animal Health, Vaxxinova, Forte Healthcare, HIPRA, Boehringer Ingelheim

    France Poultry Vaccines Market Trends

    In France, the poultry vaccines market is experiencing significant trends driven by various factors, including a growing awareness of animal health and food safety. Government initiatives aimed at enhancing biosecurity practices among poultry farmers have led to an increased demand for vaccination programs. The Ministry of Agriculture and Food in France emphasizes the importance of vaccination in preventing the spread of infectious diseases among poultry, which aligns with the global focus on improving livestock health standards. Furthermore, the rise in poultry production in France necessitates effective disease management strategies, encouraging farmers to invest in high-quality vaccines.

    Additionally, collaborations between vaccine manufacturers, veterinary associations, and educational institutions are becoming more common in France.These partnerships aim to raise awareness about the importance of vaccination and provide training for poultry farmers. This trend reflects a collective effort to elevate biosecurity measures within the poultry sector, ensuring that farmers are well-informed about vaccination protocols. 

    Overall, the France poultry vaccines market is positioned for growth, driven by a combination of health protection needs, technological advancements, and an emphasis on sustainability in production practices.

    France Poultry Vaccines Market Drivers

    Market Segment Insights

    France Poultry Vaccines Market Segment Insights

    France Poultry Vaccines Market Segment Insights

    Poultry Vaccines Market Type Insights

    Poultry Vaccines Market Type Insights

    The France Poultry Vaccines Market is divided into several types that reflect the diverse needs of poultry health management within the region. Among these, Live Attenuated Vaccines hold a significant position in the market due to their ability to stimulate a robust immune response in poultry. This type of vaccine is tailored to combat various infectious diseases that affect poultry, leading to improved health outcomes and increased productivity in the agricultural sector.

    Inactivated Vaccines are also prominent, as they provide a reliable means of immunization without the risk of causing disease, making them a preferred choice for many poultry farmers focused on biosecurity.

    The integration of Subunit Vaccines into the market showcases advancements in biotechnology, offering targeted protection by utilizing specific antigenic components to trigger immunity and thereby minimizing adverse reactions. Lastly, DNA Vaccines are emerging as an innovative option that promises enhanced efficacy and safety as they utilize genetic material to generate immune responses. This type of vaccine has the potential to revolutionize poultry health, particularly in addressing new and evolving pathogens. 

    With France's commitment to enhancing animal health and welfare, these vaccine types stand as critical components in the agricultural economy, reflecting the ongoing trends of modernization and innovation in the France Poultry Vaccines Market, which is vital for maintaining industry standards and improving overall productivity.

    Poultry Vaccines Market Species Insights

    Poultry Vaccines Market Species Insights

    The France Poultry Vaccines Market, particularly concerning the Species segment, reveals substantial insights into the dynamics shaping this sector. Broilers, Layers, Turkeys, and Others are the categories encompassed within this market, each playing a vital role in maintaining poultry health and productivity. Broilers, known for their rapid growth and high demand in the meat industry, significantly influence vaccine strategies due to their vulnerable lifecycle stages.

    Layers, on the other hand, contribute to the egg production industry, necessitating effective vaccination programs to ensure consistent output and disease prevention.Turkeys represent a niche yet pivotal segment, particularly during specific seasons where demand spikes, prompting tailored vaccination approaches. 

    The Others category includes various poultry species that further diversify the market landscape. Overall, the growth of the France Poultry Vaccines Market is driven by increasing awareness of livestock health management, advancing veterinary practices, and the need to mitigate disease outbreaks in poultry populations. Together, these factors create opportunities within these species categories, enhancing the industry's resilience and ensuring a steady supply chain in the poultry sector.

    Additionally, government regulations focused on food safety and animal welfare continue to play a crucial role in shaping vaccine development and market responses, aligning with consumer preferences for healthy and safe poultry products.

    Poultry Vaccines Market Administration Route Insights

    Poultry Vaccines Market Administration Route Insights

    The Administration Route segment of the France Poultry Vaccines Market plays a crucial role in determining vaccine efficacy and acceptance among poultry producers. Intramuscular and subcutaneous routes have historically been favored due to their reliable absorption and immune response generation, making them significant in delivering a variety of vaccines effectively. Oral administration is gaining traction because it simplifies the vaccination process, particularly in larger flocks, while also reducing labor costs and stress for the animals. 

    Inhalation methods are emerging as innovative approaches, particularly in terms of respiratory vaccines, allowing for efficient delivery directly to the site of infection.This diversification in administration routes is being driven by increased focus on biosecurity and disease prevention in the poultry industry, aligning with France's stringent animal health regulations aimed at ensuring poultry welfare and food safety. As the poultry industry in France continues to evolve, the adaptability of these administration routes will likely shape the landscape of vaccine adoption and distribution, making it a focal point for future developments in the France Poultry Vaccines Market.

    Poultry Vaccines Market Disease Targeted Insights

    Poultry Vaccines Market Disease Targeted Insights

    The Disease Targeted segment within the France Poultry Vaccines Market serves as a critical component in safeguarding poultry health and ensuring robust production in the industry. Newcastle Disease vaccines are highly significant due to their effectiveness in preventing outbreaks, which can have serious economic impacts on poultry farmers. Infectious Bursal Disease vaccines play a crucial role by targeting a virus that can severely impact young birds, thus influencing overall flock health and productivity. 

    Avian Influenza vaccines are increasingly important due to rising incidences of outbreaks, serving to protect both poultry populations and public health.Marek's Disease vaccines have also gained traction, significantly reducing mortality rates in vaccinated flocks and ensuring consistent production levels. The focus on disease-targeted vaccines is driven by the need for biosecurity and disease management, which are vital for the sustainability of the poultry industry in France. Overall, the dynamic market in France emphasizes the importance of vaccination as a proactive measure against prevalent poultry diseases, contributing to enhanced poultry health and productivity.

    Get more detailed insights about France Poultry Vaccines Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The France Poultry Vaccines Market is characterized by a robust competitive landscape, driven by the increasing demand for poultry products and the growing awareness about animal health. As poultry farming expands, the need for effective vaccines to prevent diseases among birds has become paramount. Companies in this market are focusing on innovation, research, and development to provide advanced vaccine solutions tailored to the unique needs of the poultry sector. Continuous advancements in biotechnology, coupled with regulatory support, are propelling the growth of this market. 

    The competitive dynamics are characterized by the presence of both established players and newer entrants, each striving to capture market share through strategic partnerships, mergers, and acquisitions. Understanding the strengths and market strategies of key players is essential for stakeholders looking to navigate this evolving market.Synergen has carved a notable presence in the France Poultry Vaccines Market by leveraging its expertise in research and development to produce high-quality vaccines for various poultry diseases. The company's commitment to innovation is reflected in its ability to develop customized solutions that cater specifically to the needs of poultry farmers.

    With a strong distribution network across France, Synergen ensures that its products reach a wide range of clients, from large-scale commercial operations to smaller farms. 

    The company's focus on customer service and support adds to its strengths, allowing it to build strong relationships with its client base. Additionally, Synergen invests heavily in training and education for livestock producers, contributing to improved animal welfare and productivity within the poultry sector.Cegelec has established itself as a significant player in the France Poultry Vaccines Market, with a portfolio consisting of a range of vaccines targeting different infectious diseases in poultry. 

    The company's emphasis on high-quality production processes and strict adherence to regulatory requirements has helped it build a strong reputation among poultry farmers. Cegelec's strengths lie in its comprehensive research capabilities and a well-established sales network that facilitates the distribution of its products throughout France. 

    The organization actively engages in partnerships and collaborations to enhance its product offerings and expand its market reach. In recent years, Cegelec has also pursued strategic mergers and acquisitions to bolster its position in the market, thereby enhancing its production capabilities and technological innovations. The focus on product quality, market responsiveness, and strategic growth initiatives makes Cegelec a formidable competitor in the French poultry vaccines landscape.

    Key Companies in the France Poultry Vaccines Market market include

    Industry Developments

    Recent developments in the France Poultry Vaccines Market indicate an evolving landscape characterized by innovation and strategic partnerships. Companies such as MSD Animal Health and Zoetis have been actively investing in new vaccine formulations to enhance poultry health management. Current affairs highlight the increased emphasis on biosecurity measures among poultry producers due to rising concerns over avian diseases, prompting higher demand for effective vaccination programs.

    In 2022, Vetoquinol reported expansion in their vaccine portfolio, catering specifically to local market demands.In the realm of mergers and acquisitions, familiarity has been noted with Boehringer Ingelheim acquiring IDT Biologika in March 2023, which bolstered its offerings in animal health products. 

    Furthermore, Lohmann Animal Health has been collaborating with local producers to integrate more robust vaccine solutions tailored to French poultry. Growth in market valuation, stimulated by these advancements, has resulted in heightened competition among key players including Merck Animal Health, Elanco, and Vaxxinova, significantly influencing their market positioning and strategic focus in France's poultry health sector, particularly in the domains of research and development and enhanced product availability.

    Market Segmentation

    Outlook

    • Newcastle Disease
    • Infectious Bursal Disease
    • Avian Influenza
    • Marek's Disease

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 135.0(USD Million)
    MARKET SIZE 2024 141.0(USD Million)
    MARKET SIZE 2035 260.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.721% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Synergen, Cegelec, Lohmann Animal Health, Biovac, MSD Animal Health, Zoetis, Vetoquinol, Elanco, IDT Biologika, Merck Animal Health, Vaxxinova, Forte Healthcare, HIPRA, Boehringer Ingelheim
    SEGMENTS COVERED Type, Species, Administration Route, Disease Targeted
    KEY MARKET OPPORTUNITIES Expansion of biosecurity measures, Increased demand for organic poultry, Government support for vaccination programs, Rise in poultry production, Advancements in vaccine technology
    KEY MARKET DYNAMICS Rising poultry consumption, Increasing disease outbreaks, Stringent regulatory requirements, Growing awareness of vaccination benefits, Advancements in vaccine technology
    COUNTRIES COVERED France

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the France Poultry Vaccines Market in 2024?

    The France Poultry Vaccines Market is expected to be valued at 141.0 million USD in 2024.

    What is the projected market size of the France Poultry Vaccines Market by 2035?

    By 2035, the France Poultry Vaccines Market is expected to reach a value of 260.0 million USD.

    What is the CAGR of the France Poultry Vaccines Market from 2025 to 2035?

    The expected compound annual growth rate for the France Poultry Vaccines Market between 2025 and 2035 is 5.721%.

    Which type of vaccine is expected to hold the largest market share in 2024?

    Live Attenuated Vaccines are anticipated to hold the largest market share, valued at 50.0 million USD in 2024.

    What market value is projected for Inactivated Vaccines in 2035?

    Inactivated Vaccines are projected to have a market value of 80.0 million USD by 2035.

    Which companies are considered key players in the France Poultry Vaccines Market?

    Major players include Synergen, MSD Animal Health, Zoetis, and Boehringer Ingelheim among others.

    What opportunities are driving growth in the France Poultry Vaccines Market?

    Increased poultry production and rising demand for disease prevention are key growth drivers.

    What are the expected market trends affecting the France Poultry Vaccines Market?

    Emerging trends include advancements in vaccine technology and growing consumer awareness about poultry health.

    How does the market for Subunit Vaccines look by 2035?

    The market for Subunit Vaccines is expected to reach 60.0 million USD by 2035.

    What challenges might impact the France Poultry Vaccines Market moving forward?

    Challenges may include regulatory hurdles and the need for continuous innovation to combat evolving diseases.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. France Poultry Vaccines Market, BY Type (USD Million)
    45. Live Attenuated Vaccines
    46. Inactivated Vaccines
    47. Subunit Vaccines
    48. DNA Vaccines
    49. France Poultry Vaccines Market, BY Species (USD Million)
    50. Broilers
    51. Layers
    52. Turkeys
    53. Others
    54. France Poultry Vaccines Market, BY Administration Route (USD Million)
    55. Intramuscular
    56. Subcutaneous
    57. Oral
    58. Inhalation
    59. France Poultry Vaccines Market, BY Disease Targeted (USD Million)
    60. Newcastle Disease
    61. Infectious Bursal Disease
    62. Avian Influenza
    63. Marek's Disease
    64. Competitive Landscape
    65. Overview
    66. Competitive Analysis
    67. Market share Analysis
    68. Major Growth Strategy in the Poultry Vaccines Market
    69. Competitive Benchmarking
    70. Leading Players in Terms of Number of Developments in the Poultry Vaccines Market
    71. Key developments and growth strategies
    72. New Product Launch/Service Deployment
    73. Merger & Acquisitions
    74. Joint Ventures
    75. Major Players Financial Matrix
    76. Sales and Operating Income
    77. Major Players R&D Expenditure. 2023
    78. Company Profiles
    79. Synergen
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Cegelec
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. Lohmann Animal Health
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Biovac
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. MSD Animal Health
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Zoetis
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Vetoquinol
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Elanco
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. IDT Biologika
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Merck Animal Health
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Vaxxinova
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Forte Healthcare
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. HIPRA
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Boehringer Ingelheim
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. References
    164. Related Reports
    165. France Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    166. France Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY SPECIES, 2019-2035 (USD Billions)
    167. France Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
    168. France Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY DISEASE TARGETED, 2019-2035 (USD Billions)
    169. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    170. ACQUISITION/PARTNERSHIP
    171. MARKET SYNOPSIS
    172. FRANCE POULTRY VACCINES MARKET ANALYSIS BY TYPE
    173. FRANCE POULTRY VACCINES MARKET ANALYSIS BY SPECIES
    174. FRANCE POULTRY VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
    175. FRANCE POULTRY VACCINES MARKET ANALYSIS BY DISEASE TARGETED
    176. KEY BUYING CRITERIA OF POULTRY VACCINES MARKET
    177. RESEARCH PROCESS OF MRFR
    178. DRO ANALYSIS OF POULTRY VACCINES MARKET
    179. DRIVERS IMPACT ANALYSIS: POULTRY VACCINES MARKET
    180. RESTRAINTS IMPACT ANALYSIS: POULTRY VACCINES MARKET
    181. SUPPLY / VALUE CHAIN: POULTRY VACCINES MARKET
    182. POULTRY VACCINES MARKET, BY TYPE, 2025 (% SHARE)
    183. POULTRY VACCINES MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    184. POULTRY VACCINES MARKET, BY SPECIES, 2025 (% SHARE)
    185. POULTRY VACCINES MARKET, BY SPECIES, 2019 TO 2035 (USD Billions)
    186. POULTRY VACCINES MARKET, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
    187. POULTRY VACCINES MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
    188. POULTRY VACCINES MARKET, BY DISEASE TARGETED, 2025 (% SHARE)
    189. POULTRY VACCINES MARKET, BY DISEASE TARGETED, 2019 TO 2035 (USD Billions)
    190. BENCHMARKING OF MAJOR COMPETITORS

    France Poultry Vaccines Market Segmentation

     

     

     

    • Poultry Vaccines Market By Type (USD Million, 2019-2035)

      • Live Attenuated Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • DNA Vaccines

     

    • Poultry Vaccines Market By Species (USD Million, 2019-2035)

      • Broilers
      • Layers
      • Turkeys
      • Others

     

    • Poultry Vaccines Market By Administration Route (USD Million, 2019-2035)

      • Intramuscular
      • Subcutaneous
      • Oral
      • Inhalation

     

    • Poultry Vaccines Market By Disease Targeted (USD Million, 2019-2035)

      • Newcastle Disease
      • Infectious Bursal Disease
      • Avian Influenza
      • Marek's Disease

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027